Skip to content
★ Sign in to follow
Medical Developments International Limited logo

Medical Developments International Limited Stock: price and insider trades · Australia

ISIN AU000000MVP2AU·Mcap A$41.7MHealth Care

Medical Developments International Limited: what insiders have been doing

Medical Developments International Limited, founded in 1971, is a Health Care company based in Victoria, Australia. Its directors and officers file their transactions with ASX. From 29 October 2025 to 29 October 2026, the disclosure feed for Medical Developments International Limited logged 5 filings by 4 insiders.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

For context, the typical company on the same exchange (median of 1,606 companies) published 5 filings over the same period, against 5 filings here.

No insider has bought Medical Developments International Limited shares on the open market in the past twelve months.

In the same sector, recent insider purchases at Dynavox Group AB and EssilorLuxottica also feature in our signals. Source: insider filings from ASX. Past trades are no guide to future returns.

Key facts

Headquarters: Victoria, Australia · Founded: 1971

Source: Wikidata (CC0).

Insider Decl.
5
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a

Analyst consensus: bullish or bearish?

Analysts rate Medical Developments International Limited Strong Buy (bullish), based on 2 analysts. Average price target: A$2.30.

Fundamental score
Ranked 11,668 of 26,912 companies
55.0
score / 100
Value
52
Quality
58
FCF yld11%
Earn yld1.4%
EV/EBITDA14.4x
ROE1.1%
Gross mgn72%
Net mgn1.5%
Debt/EBITDA0.5x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2026

FY ended June 2026 · cache

A$0.37
Analyst consensus
2 analysts
Strong buy
A$1.00Target A$2.30(+522%)A$3.60
Income statement
RevenueA$42.6M
Gross profitA$30.7M72% margin
EBITDAA$3.3M8% margin
Net incomeA$626k1.5% margin
Valuation
PER (trailing)37.0x
PER (forward)9.9x
P/Book0.7x
Beta1.56
Balance sheet & cash
Market capA$41.7M
Total debtA$1.7M
Free Cash FlowA$5M
Debt / Equity3%
Profitability & ownership
ROE1.1%
ROA2.3%
% insiders23.9%
% institutions24.0%
Last declaration on 29 October 2026
Declarations5 total
  • ●
    Unknown Substantial Holder
    Substantial HolderExecutives(filed)
    0ASX
    ShareASXASX:2924-03155341-3A705345
  • ●
    Related company / holdingExecutives(filed)
    0ASX
    ShareASXASX:2924-03121907-3A698951
  • ●
    Substantial HolderExecutives(filed)
    0ASX
    ShareASXASX:2924-03106330-3A696380
  • ●
    Substantial HolderExecutives(filed)
    0ASX
    ShareASXISIN AU000000MVP2ASX:2924-03096845-3A694663
  • ●
    Related company / holdingExecutives(filed)
    0ASX
    ShareASXISIN AU000000MVP2ASX:2924-03096297-3A694553

5 of 5 declarations

About Medical Developments International Limited

Medical Developments International Limited is an Australian company focused on developing medical products, particularly pain management devices. It is listed on the Australian Securities Exchange under the ticker XASX.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations